Outbreak, epidemic or pandemic risk

Diphtheria, though largely controlled in many regions thanks to vaccination, outbreaks are still reported today, especially in populations with low immunization coverage, high mobility, or poor living conditions. Go to footnote 1 Diphtheria outbreaks have been reported in various settings, including refugee camps in Asia, and among asylum seekers in Europe. Go to footnote 2, Go to footnote 3 
Tetanus is generally rare in areas with high vaccination coverage, and since it is acquired from environmental sources, it does pose a risk for outbreaks. Go to footnote 4
Pertussis has a well-documented history of causing outbreaks, even in populations with high vaccination coverage. Recent trends show that pertussis continues to have significant outbreak potential worldwide, affecting both children and adults, and posing particular risks to infants. Go to footnote 5, Go to footnote 6 
Hepatitis B has significant potential for outbreaks, especially in settings with poor infection control or low vaccination coverage. Outbreaks of hepatitis B have been documented in both healthcare and community settings, and the virus remains a persistent public health threat in many regions. Go to footnote 7, Go to footnote 8 
Prior to widespread vaccination, small outbreaks or clusters of cases of Hib disease have been noted in day-care centres and there were reports of nosocomial transmission in hospitals. The risk of Hib disease was also higher in larger families. Go to footnote 9
The risk of poliovirus outbreaks and localised epidemics remains significant in areas with low vaccination coverage, fragile health systems, or gaps in immunization campaigns, particularly in regions experiencing conflict or displacement. Wild poliovirus (WPV) is endemic to Afghanistan and Pakistan, while vaccine-derived poliovirus (cVDPV) outbreaks have been reported in 20 countries in 2024. There is a rising risk of outbreaks of cVDPV2 since the global switch to bivalent oral poliovirus vaccine (bOPV). Although the global pandemic potential is low due to widespread immunity and effective vaccines, lapses in immunization and surveillance have led to the detection of poliovirus in environmental samples in previously polio-free countries. Go to footnote 10, Go to footnote 11, Go to footnote 12, Go to footnote 13   

Sources
  • Go back to footnote reference 1

    Centers for Disease Control and Prevention (no date). Diphtheria: Chapter 1. In: Surveillance Manual. Atlanta: CDC. Available at: https://www.cdc.gov/surv-manual/php/table-of-contents/chapter-1-diphtheria.html (accessed 1 July 2025).

  • Go back to footnote reference 2

    Fatihatun R, Adnan N, Laila N (2024). Diphtheria outbreak in Serang City, Banten, Indonesia, 2024: epidemiological investigation and response. J Teknol Kesehat Borneo. doi:10.30602/jtkb.v5i2.354.

  • Go back to footnote reference 3

    Brockhaus L, Urwyler P, Leutwyler U, Würfel E, Vasconcelos M, Goldenberger D et al. (2024). Diphtheria in a Swiss asylum seeker reception centre: outbreak investigation and evaluation of testing and vaccination strategies. Int J Public Health. doi:10.3389/ijph.2024.1606791.

  • Go back to footnote reference 4

    Finkelstein P, Teisch L, Allen C, Ruiz G (2017). Tetanus: a potential public health threat in times of disaster. Prehosp Disaster Med. 32:339–342. doi:10.1017/S1049023X17000012.

  • Go back to footnote reference 5

    Khalil A, Samara A, Campbell H, Ladhani SN, Amirthalingam G (2024). Recent increase in infant pertussis cases in Europe and the critical importance of antenatal immunizations: we must do better…now. Int J Infect Dis. 146:107148. doi:10.1016/j.ijid.2024.107148.

  • Go back to footnote reference 6

    Bricks LF, Vargas-Zambrano JC, Macina D (2024). Epidemiology of pertussis after the COVID-19 pandemic: analysis of the factors involved in the resurgence of the disease in high-, middle-, and low-income countries. Vaccines (Basel). 12(12):1346. doi:10.3390/vaccines12121346.

  • Go back to footnote reference 7

    Lanini S, Puro V, Lauria F, Fusco F, Nisii C, Ippolito G (2009). Patient to patient transmission of hepatitis B virus: a systematic review of reports on outbreaks between 1992 and 2007. BMC Med. 7:15. doi:10.1186/1741-7015-7-15.

  • Go back to footnote reference 8

    Lee C, Emeto T, Walsh N (2022). Prevalence of hepatitis B virus amongst refugees, asylum seekers and internally displaced persons in low‐ and middle‐income countries: a systematic review. J Viral Hepat. 30:4–18. doi:10.1111/jvh.13770.

  • Go back to footnote reference 9

    Shane AL, Pickering LK (2012). Infections associated with group childcare. In: Cherry JD, Demmler-Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ, editors. Principles and practice of pediatric infectious diseases. 4th ed. Philadelphia: Elsevier Saunders; 2012:24–32.e6. doi:10.1016/B978-1-4377-2702-9.00102-1.

  • Go back to footnote reference 10

    Polio vaccines: WHO position paper, June 2022. Weekly Epidemiological Record. 2022; 97(25): 277–296.7.

  • Go back to footnote reference 11

    Wild poliovirus count. In: Global Polio Eradication Initiative [website]. Geneva: Global Polio Eradication Initiative; 2025 (https://polioeradication.org/wild-poliovirus-count/, accessed 24 June 2025).

  • Go back to footnote reference 12

    Circulating vaccine-derived poliovirus count. In: Global Polio Eradication Initiative [website]. Geneva: Global Polio Eradication Initiative; 2025 (https://polioeradication.org/circulating-vaccine-derived-poliovirus-count/, accessed 24 June 2025).

  • Go back to footnote reference 13

    Namageyo-Funa A, Greene SA, Henderson E, et al. (2024). Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2023–June 2024. MMWR Morb Mortal Wkly Rep. 2024;73:909–916. DOI: http://dx.doi.org/10.15585/mmwr.mm7341a1